FUS
RNA-binding protein FUS
Also known as: ALS6, FUS_HUMAN, FUS1, hnRNP-P2, HNRNPP2, TLS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35637
- Gene
- FUS
- Ensembl
- ENSG00000089280
- Chromosome
- 16
- Canonical length
- 526 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a multifunctional protein component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex. The hnRNP complex is involved in pre-mRNA splicing and the export of fully processed mRNA to the cytoplasm. This protein belongs to the FET family of RNA-binding proteins which have been implicated in cellular processes that include regulation of gene expression, maintenance of genomic integrity and mRNA/microRNA processing. Alternative splicing results in multiple transcript variants. Defects in this gene result in amyotrophic lateral sclerosis type 6. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
526 residues, UniProt reviewed canonical sequence.
>P35637|FUS
1 MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTSGY GQSSYSSYGQ
61 SQNTGYGTQS TPQGYGSTGG YGSSQSSQSS YGQQSSYPGY GQQPAPSSTS GSYGSSSQSS
121 SYGQPQSGSY SQQPSYGGQQ QSYGQQQSYN PPQGYGQQNQ YNSSSGGGGG GGGGGNYGQD
181 QSSMSSGGGS GGGYGNQDQS GGGGSGGYGQ QDRGGRGRGG SGGGGGGGGG GYNRSSGGYE
241 PRGRGGGRGG RGGMGGSDRG GFNKFGGPRD QGSRHDSEQD NSDNNTIFVQ GLGENVTIES
301 VADYFKQIGI IKTNKKTGQP MINLYTDRET GKLKGEATVS FDDPPSAKAA IDWFDGKEFS
361 GNPIKVSFAT RRADFNRGGG NGRGGRGRGG PMGRGGYGGG GSGGGGRGGF PSGGGGGGGQ
421 QRAGDWKCPN PTCENMNFSW RNECNQCKAP KPDGPGGGPG GSHMGGNYGD DRRGGRGGYD
481 RGGYRGRGGD RGGFRGGRGG GDRGGFGPGK MDSRGEHRQD RRERPYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FUS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 162 nTPM
Expression across tissuesHPA
Tissue
- thymus: 162 nTPM
- ovary: 148 nTPM
- cerebellum: 122 nTPM
- skeletal muscle: 113 nTPM
- endometrium: 109 nTPM
- tonsil: 106 nTPM
Single-cell type
- sertoli cells: 564 nCPM
- extravillous trophoblasts: 511 nCPM
- epididymal basal cells: 433 nCPM
- leydig cells: 393 nCPM
- ovarian stromal cells: 393 nCPM
- migrating cytotrophoblasts: 379 nCPM
Immune cell
- intermediate monocyte: 67 nTPM
- non-classical monocyte: 60 nTPM
- gdT-cell: 54 nTPM
- eosinophil: 53 nTPM
- plasmacytoid DC: 50 nTPM
- MAIT T-cell: 50 nTPM
Brain region
- cerebral cortex: 93 nTPM
- cerebellum: 82 nTPM
- white matter: 82 nTPM
- hypothalamus: 79 nTPM
- basal ganglia: 77 nTPM
- pons: 74 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FUS.
Disease | AllUniProt
Conditions FUS is implicated in, by any mechanism.
- Angiomatoid fibrous histiocytoma (AFH) MIM:612160
- Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) MIM:608030
- Tremor, hereditary essential 4 (ETM4) MIM:614782
Disease | GeneticClinVar
51 pathogenic / likely-pathogenic of 683 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Amyotrophic lateral sclerosis type 6
- Tremor, hereditary essential, 4
- FUS-related disorder
- Juvenile amyotrophic lateral sclerosis
- Amyotrophic lateral sclerosis 6, autosomal recessive
Disease | ImmuneIEDB
Conditions an epitope on FUS was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.21
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amyloid fibril formation
- membraneless organelle assembly
- mRNA stabilization
- positive regulation of double-strand break repair via homologous recombination
- protein homooligomerization
- regulation of DNA-templated transcription
- regulation of RNA splicing
- regulation of transcription by RNA polymerase II
- RNA splicing
Molecular functions
- chromatin binding
- DNA binding
- identical protein binding
- molecular condensate scaffold activity
- mRNA 3'-UTR binding
- RNA binding
- transcription coactivator activity
- transcription coregulator activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FUS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FUS as an antibody target. Whether an autoantibody or antibody against FUS could matter depends on whether native FUS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FUS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FUS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...